Vetanco at the 2022 IPVS Congress

Vetanco attended and sponsored the most important scientific event of the global swine industry, the 26th International Pig Veterinary Society Congress (IPVS).

The 2022 IPVS was held in Rio de Janeiro and was organized by the Brazilian Association of Swine Veterinary Specialists (Abraves).

Vetanco participated in the event together with its subsidiaries in Brazil, Argentina, Guatemala, Costa Rica, Panama, and Mexico, as well as its distributors from different Latin American countries.

In addition, members of the laboratory shared three scientific papers. One of them referred to the Uniwall Mos product: “Use of prebiotic additive in pregnant and lactating females as an alternative to improve birth and weaning weights“, by David Saldivar, Nicolás Fermentini, Carlos Cedeño, and Eduardo Miotto (Vetanco Mexico and Brazil), with contributions from Jerffeson Araujo Cavalcante (Icasa).

“We are part of the history of the most important congress of swine global production. We are enormously proud of our customers and our technical sales staff, which always provides the right products to solve the common problems in swine production“, pointed out Gustavo Orella, Technical Sales Coordinator at the Swine Division of Vetanco SA.

The stand was also attended by Dr. Arpad Bata, CEO of the Hungarian laboratory Dr. Bata Ltd., a strategic partner of Vetanco with whom they created BV Science.

BV Science is a joint venture that operates in the North American market. It was created in 2016 from the merger between the research, marketing, and technical support departments of Dr. Bata Ltd. in Europe and Asia and Vetanco S.A. in the Americas.

Dr. Bata Ltd.’s first steps in Brazil were recently announced in a ceremony held in the land where its first Brazilian factory will be built, next to Vetanco headquarters, in Chapecó/SC. This is the largest investment plan in Brazil in the 20th century.

The facility will occupy about 3,000 square meters, with high-tech equipment. The project will also include a quality control laboratory, an analysis and diagnostic laboratory, and research and development focused on the production of eubiotics. More than BRL 30 million will be invested in the entire project.